Severity of human African trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile

Infection and Immunity

Volumn 72, Issue 12, 2004, Pages 7040-7044

  MacLean, Lorna ^e   Chisi, John E ^a   Odiit, Martin ^b   Gibson, Wendy C ^c   Ferris, Vanessa ^c   Picozzi, Kim ^d   Sternberg, Jeremy M ^e  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Livestock Health Research Institute   (Uganda)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AFRICA; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CHILD; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; GENE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALAWI; MENINGOENCEPHALITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PARASITE VIRULENCE; PHENOTYPE; PRIORITY JOURNAL; SERUM RESISTANCE ASSOCIATED GENE; TRYPANOSOMA BRUCEI; UGANDA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE PROGRESSION; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9244247322     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.12.7040-7044.2004     Document Type: Article

References (27)

1. Bellone, G., G. Aste-Amezaga, G. Trinchieri, and U. Rodeck. 1995. Regulation of NK-cell functions by TGF-beta1. J. Immunol. 155:1066-1073.
2. Buyst, H. 1977. The epidemiology of sleeping sickness in the historical Luangwa valley. Ann. Soc. Belg. Med. Trop. 57:349-359.
3. Cattand, P., B. T. Miezan, and P. de Raadt. 1988. Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bull. W. H. O. 66:83-86.
4. de Almeida, P. P., M. Ndao, N. Van Meirvenne, and S. Geerts. 1998. Diagnostic evaluation of PCR on dried blood samples from goats experimentally infected with Trypanosoma brucei brucei. Acta Trop. 70:269-276.
5. Duggan, A. J., and M. P. Hutchinson. 1966. Sleeping sickness in Europeans: a review of 109 cases. J. Trop. Med. Hyg. 69:124-131.
6. Enanga, B., R. S. Burchmore, M. L. Stewart, and M. P. Barrett. 2002. Sleeping sickness and the brain. Cell. Mol. Life Sci. 59:845-858.
7. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shephard, and M. A. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571-576.
8. Gelfand, M. 1966. The early clinical features of Rhodesian trypanosomiasis with special reference to the 'chancre' (local reaction). Trans. R. Soc. Trop. Med. Hyg. 60:376-379.
9. Gibson, W. 2002. Will the real Trypanosoma brucei please step forward? Trends Parasitol. 18:486-490.
10. Gibson, W., T. Backhouse, and A. Griffiths. 2002. The human serum associated gene is ubiquitous and conserved in Trypanosoma brucei brucei throughout East Africa. Infect. Genet. Evol. 1:207-214.
11. Gibson, W., and V. Ferris. 2003. Conservation of the genomic location of the human serum resistance associated gene in Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 130:159-162.
12. Godfrey, D. G., R. D. Baker, L. R. Rickman, and D. Mehlitz. 1990. The distribution, relationships and identification of enzymic variants within the subgenus Trypanozoon. Adv. Parasitol. 29:1-74.
13. Hide, G., N. Buchanan, S. C. Welburn, I. Maudlin, and J. D. Barry. 1991. Trypanosoma brucei rhodesiense: characterisation of stocks from Zambia, Kenya and Uganda using repetitive DNA probes. Exp. Parasitol. 72:430-439.
14. Kabiri, M., J. R. Franco, P. P. Simarro, J. A. Ruiz, M. Sarsa, and D. Steverding. 1999. Detection of Trypanosoma brucei gambiense in sleeping sickness suspects by PCR amplification of expression-site-associated genes 6 and 7. Trop. Med. Int. Health 4:658-661.
15. Lejon, V., J. Lardon, G. Kenis, L. Pinoges, D. Legros, S. Bisser, X. N'Siesi, E. Bosmans, and P. Buscher. 2002. Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans. R. Soc. Trop. Med. Hyg. 96:329-333.
16. MacLean, L., M. Odiit, and J. M. Sternberg. 2001. Nitric oxide and cytokine synthesis in human African trypanosomiasis. J. Infect. Dis. 184:1086-1090.
17. Magez, S., M. Radwanska, A. Beschin, K. Sekikawa, and P. De Baetseller. 1999. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun. 67:3128-3132.
18. Magez, S., B. Stijlemans, T. Baral, and P. De Baetselier. 2002. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect. 4:999-1006.
19. Namangala, B., W. Noel, P. De Baetselier, L. Brys, and A. Beschin. 2001. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J. Infect. Dis. 183:1794-1800.
20. Ormerod, W. E. 1967. Taxonomy of the sleeping sickness trypanosomes. J. Parasitol. 53:824-830.
21. Quan, N., L. He, and W. Lai. 2003. Intraventricular infusion of antagonists of IL-1 and TNF-alpha attenuates neurodegeneration induced by the infection of Trypanosoma brucei. J. Neuroimmunol. 138:92-98.
22. Radwanska, M., M. Chamekh, L. Vanhamme, F. Claes, S. Magez, E. Magnus, P. De Baetselier, P. Buscher, and E. Pays. 2002. The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am. J. Trop. Med. Hyg. 67:684-690.
23. Vanhamme, L., F. Paturiaux-Hanocq, P. Poelvoorde, D. Nolan, L. Lins, J. Van den Abbeele, A. Pays, P. Tebabi, H. Xong, A. Jacquet, N. Moguilevsky, M. Dieu, J. P. Kane, P. De Baetselier, R. Brasseur, and E. Pays. 2003. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422:83-87.
24. Wahl, S. M., N. McArtney-Francis, and S. E. Mergenhagen. 1989. Inflammatory and immunomodulatory roles of TGF-beta. Immunol. Today 10:258-261.
25. Welburn, S. C., K. Picozzi, E. M. Fevre, P. G. Coleman, M. Odiit, M. Carrington, and I. Maudlin. 2001. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet 358:2017-2019.
26. Woo, P. T. 1971. Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. Acta Trop. 28:298-303.
27. Xong, H. V., L. Vanhamme, M. Chamekh, C. E. Chimfwembe, J. Van Den Abbeele, A. Pays, N. Van Meirvenne, R. Hamers, P. De Baetselier, and E. Pays. 1998. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95:839-846.